RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Nathan Vandergrift

Nathan Vandergrift

Senior Research Statistician


PhD, Quantitative Psychology, University of North Carolina
BA, Philosophy & Cognitive Science, University of Arizona


Nathan Vandergrift, PhD, is a research statistician with 20 years of experience in collaborative research. He has led numerous multisite research groups, both domestic and international, and has a depth of experience with large cooperative National Institutes of Health (NIH) studies (e.g. UM1, P01) and contracts, as well as Department of Defense (DoD) networks. He has subject matter experience with biomedicine, social science, and education policy.

Dr. Vandergrift is an expert statistical analyst, specializing in structural equation modeling, nonlinear and linear mixed-effects modeling, generalized linear models, nonparametric statistics, missing data, and statistical matching. Currently, he applies his statistical expertise and leadership skills to several federally funded, multisite networks focused on data-driven solutions to pressing public health concerns. Some of his current research projects include the Centers for Research in Emerging Infectious Diseases (CREID) [NIH/National Institute of Allergy and Infectious Disease (NIAID)], the HEALing Communities Study (HCS) [NIH/National Institute on Drug Abuse (NIDA)], and the Pharmacotherapies for Substance Abuse and dependence (PASA) [DoD].

Prior to joining RTI in 2018, Dr. Vandergrift was the director of biostatistics for the Duke Human Vaccine Institute and the Center for HIV/AIDS Vaccine Immunology. His research focused on novel detection and characterization methods, immunological responses, translational medicine from bench treatment, and interventions both pharmaceutical and behavioral. He also has former experience with education and childhood development research among at risk populations.

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics